PHARMACEUTICAL USE OF HEXAHYDRO-DIBENZO[A,G]QUINOLIZINE COMPOUNDS
申请人:Shanghai Institute of Materia Medica,
Chinese Academy of Sciences
公开号:EP2992883A1
公开(公告)日:2016-03-09
Use of hexahydro-dibenzo[a,g]quinolizine compounds as shown in formula(I) in preparing a medicine for treating and/or preventing benign prostate hyperplasia diseases.
如式(I)所示六氢-二苯并[a,g]喹嗪化合物在制备治疗和/或预防良性前列腺增生疾病药物中的用途。
CELEWICZ, LECH;SPYCHALA, JAROSLAW;GOLANKIEWICZ, KRZYSZTOF, SYNTH. COMMUN., 17,(1987) N 16, 1939-1950
作者:CELEWICZ, LECH、SPYCHALA, JAROSLAW、GOLANKIEWICZ, KRZYSZTOF